Portfolio (Quarterly)
Guide ↗
Velan Capital Investment Management LP
· CIK 0001848809| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | — | ANTERIS TECHNOLOGIES GLOBAL | — | 700,000.0 | $3.9M | 2.43% | NEW | — | $5.55 | — |
| 2 | XNCR | XENCOR INC | Healthcare | 250,000.0 | $3.0M | 1.89% | NEW | — | $12.06 | -6.2% |
| 3 | LYEL | LYELL IMMUNOPHARMA INC | Healthcare | 102,000.0 | $2.0M | 1.28% | NEW | — | $20.06 | -13.0% |
| 4 | RCKT | ROCKET PHARMACEUTICALS INC | Healthcare | 294,643.0 | $1.1M | 0.66% | NEW | — | $3.58 | -17.3% |
| 5 | — | NASUS PHARMA LTD | — | 359,390.0 | $798K | 0.50% | NEW | — | $2.22 | — |
| 6 | QNRX | QUOIN PHARMACEUTICALS LTD | Healthcare | 84,849.0 | $560K | 0.35% | NEW | — | $6.60 | -27.7% |
| 7 | — | ARTIVA BIOTHERAPEUTICS INC | — | 25,000.0 | $161K | 0.10% | NEW | — | $6.44 | — |
| 8 | NMRA | NEUMORA THERAPEUTICS INC. | Healthcare | 80,000.0 | $156K | 0.10% | NEW | — | $1.95 | -5.1% |
| 9 | XLO | XILIO THERAPEUTICS INC | Healthcare | 14,285.0 | $120K | 0.07% | NEW | — | $8.41 | -1.9% |
| 10 | KLRS | KALARIS THERAPEUTICS INC | Healthcare | 18,000.0 | $104K | 0.07% | NEW | — | $5.77 | -14.7% |
| 11 | MGNX | MACROGENICS INC | Healthcare | 30,000.0 | $87K | 0.05% | NEW | — | $2.89 | +56.7% |
| 12 | KPTI | KARYOPHARM THERAPEUTICS INC | Healthcare | 15,000.0 | $84K | 0.05% | NEW | — | $5.57 | +46.5% |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Healthcare
100.0%